Horizon Therapeutics Plc


Market Cap$0

Compare Horizon Therapeutics Plc

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Horizon Therapeutics PlcHorizon Therapeutics Plc00%8%7.80.5
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Current Fair Value

6.3% upside

Undervalued by 6.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$92.84 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$1.87
Outstanding Shares228,994,568
Avg 30 Day Volume0


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales7.75
Price to Book Ratio5.06
Enterprise Value to Revenue0.03
Enterprise Value to EBIT0.18
Enterprise Value to Net Income0
Total Debt to Enterprise27.55
Debt to Equity0.48

Revenue Sources

No data

ESG Score

No data

About Horizon Therapeutics Plc